PL354262A1 - Torsemide polymorphs - Google Patents
Torsemide polymorphsInfo
- Publication number
- PL354262A1 PL354262A1 PL00354262A PL35426200A PL354262A1 PL 354262 A1 PL354262 A1 PL 354262A1 PL 00354262 A PL00354262 A PL 00354262A PL 35426200 A PL35426200 A PL 35426200A PL 354262 A1 PL354262 A1 PL 354262A1
- Authority
- PL
- Poland
- Prior art keywords
- torsemide
- polymorphs
- torsemide polymorphs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14830599P | 1999-08-11 | 1999-08-11 | |
US18312700P | 2000-02-17 | 2000-02-17 | |
US21527300P | 2000-06-30 | 2000-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL354262A1 true PL354262A1 (en) | 2003-12-29 |
Family
ID=27386674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL00354262A PL354262A1 (en) | 1999-08-11 | 2000-08-11 | Torsemide polymorphs |
Country Status (24)
Country | Link |
---|---|
US (1) | US6465496B1 (en) |
EP (1) | EP1207880A4 (en) |
JP (1) | JP2003527319A (en) |
KR (1) | KR20020025217A (en) |
CN (1) | CN1378448A (en) |
AU (1) | AU781461C (en) |
BG (1) | BG106400A (en) |
CA (1) | CA2379322A1 (en) |
CZ (1) | CZ2002404A3 (en) |
DE (1) | DE00957398T1 (en) |
ES (1) | ES2204354T1 (en) |
HK (1) | HK1046636A1 (en) |
HR (1) | HRP20020120A2 (en) |
HU (1) | HUP0204318A3 (en) |
IL (1) | IL148031A0 (en) |
LT (1) | LT5004B (en) |
MX (1) | MXPA02001369A (en) |
NO (1) | NO20020622L (en) |
PL (1) | PL354262A1 (en) |
SI (1) | SI20816A (en) |
SK (1) | SK1912002A3 (en) |
TR (1) | TR200200353T2 (en) |
WO (1) | WO2001010441A1 (en) |
YU (1) | YU9502A (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2193007T3 (en) * | 2000-02-17 | 2004-11-01 | Teva Pharmaceutical Industries Ltd. | STABLE PHARMACEUTICAL FORMULATION THAT INCLUDES MODIFICATION II OF TORSEMIDE. |
DE10013289A1 (en) * | 2000-03-17 | 2001-09-20 | Knoll Ag | Storage-stable formulations containing diuretic torasemide, are solids or semi-solids containing the active agent in non-crystalline form, e.g. as solid solution in vinyl pyrrolidone polymer matrix |
HRP20000162B1 (en) | 2000-03-20 | 2004-06-30 | Pliva D D | Amorphous torasemide modification |
US20030022921A1 (en) * | 2001-02-21 | 2003-01-30 | Minutza Leibovici | Stable pharmaceutical formulation comprising torsemide modification II |
CA2448279A1 (en) | 2001-05-31 | 2002-12-05 | Orion Corporation Fermion | Process for preparing sertraline hydrochloride polymorphic form ii |
IN192178B (en) * | 2001-08-03 | 2004-03-06 | Ranbaxy Lab | |
US20030119882A1 (en) * | 2001-10-22 | 2003-06-26 | Markus Maegerlein | Solid pharmaceutical composition containing torasemide |
ITMI20020639A1 (en) * | 2002-03-27 | 2003-09-29 | Cosma S P A | PHARMACEUTICAL COMPOSITIONS INCLUDING AS ACTIVE INGREDIENT 1-ISOPROPIL-3 ° (4-M-TOLUIDINO-3-PRIDIL) SULFONIL! -UREA |
HRP20020603B1 (en) * | 2002-07-19 | 2008-11-30 | Pliva D.D. | New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide |
CA2424644A1 (en) * | 2003-04-07 | 2004-10-07 | David John Mckenzie | Preparation of torasemide |
ES2244324B1 (en) * | 2004-03-25 | 2006-11-16 | Ferrer Internacional, S.A. | DIURETIC COMPOSITIONS OF PROLONGED RELEASE. |
AT500576B1 (en) * | 2004-07-28 | 2006-11-15 | Sanochemia Pharmazeutika Ag | PROCESS FOR REPRESENTING CRYSTAL FORMS OF TORSEMID |
KR100845383B1 (en) * | 2004-12-24 | 2008-07-09 | 일동제약주식회사 | Process for preparing torsemide modification? |
WO2007064595A2 (en) * | 2005-11-29 | 2007-06-07 | Bausch & Lomb Incorporated | Fluocinolone acetonide drug substance polymorphic interconversion |
PE20160945A1 (en) | 2013-11-15 | 2016-09-26 | Akebia Therapeutics Inc | SOLID FORMS OF {[5- (3-CHLOROPHENYL) -3-HYDROXYPYRIDIN-2-CARBONYL] AMINO} ACID, COMPOSITIONS, AND USES OF THEM |
CN105949115A (en) * | 2016-05-26 | 2016-09-21 | 南京正科医药股份有限公司 | Novel crystal form torasemide |
CN115417810B (en) * | 2022-09-22 | 2023-10-10 | 南京正科医药股份有限公司 | Refining method of torsemide crystal form I |
CN117486789A (en) * | 2023-12-29 | 2024-02-02 | 江西中医药大学 | Torase Mi Gongjing salt and preparation method and application thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US34672A (en) | 1862-03-18 | Improved convertible boat, bridge, and tent | ||
US30633A (en) | 1860-11-13 | Improvement in fire-escapes | ||
US4055650A (en) | 1974-04-17 | 1977-10-25 | A. Christiaens Societe Anonyme | Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines |
GB1477664A (en) * | 1974-04-17 | 1977-06-22 | Christiaens Sa A | Pyridine derivatives |
DE3529529A1 (en) | 1985-08-17 | 1987-02-19 | Boehringer Mannheim Gmbh | METHOD FOR PRODUCING A STABLE MODIFICATION OF TORASEMIDE |
DE3623620A1 (en) | 1986-07-12 | 1988-01-21 | Boehringer Mannheim Gmbh | MOLDABLE, AQUEOUS, ALKALINE INJECTION SOLUTIONS FROM TORASEMID AND METHOD FOR THE PRODUCTION THEREOF |
HRP980532B1 (en) * | 1998-10-02 | 2005-06-30 | Pliva | Novel crystalline torasemide modification |
US6166045A (en) * | 1998-06-02 | 2000-12-26 | Roche Diagnostics Gmbh | Torasemide of modification III |
US5914336A (en) * | 1998-06-02 | 1999-06-22 | Boehringer Mannheim Gmbh | Method of controlling the serum solubility of orally administered torasemide and composition relating thereto |
HRP20000162B1 (en) * | 2000-03-20 | 2004-06-30 | Pliva D D | Amorphous torasemide modification |
PL370039A1 (en) * | 2000-03-20 | 2005-05-16 | Teva Pharmaceutical Industries Ltd. | Novel processes for preparing torsemide intermediate |
HRP20000328A2 (en) * | 2000-05-19 | 2002-02-28 | Pliva Farmaceutska Ind Dionik | Novel polymorph v of torasemide |
-
2000
- 2000-08-11 EP EP00957398A patent/EP1207880A4/en not_active Withdrawn
- 2000-08-11 HU HU0204318A patent/HUP0204318A3/en unknown
- 2000-08-11 PL PL00354262A patent/PL354262A1/en not_active Application Discontinuation
- 2000-08-11 KR KR1020027001867A patent/KR20020025217A/en not_active Application Discontinuation
- 2000-08-11 DE DE0001207880T patent/DE00957398T1/en active Pending
- 2000-08-11 AU AU69026/00A patent/AU781461C/en not_active Ceased
- 2000-08-11 SI SI200020037A patent/SI20816A/en not_active IP Right Cessation
- 2000-08-11 US US09/638,106 patent/US6465496B1/en not_active Expired - Fee Related
- 2000-08-11 YU YU9502A patent/YU9502A/en unknown
- 2000-08-11 CZ CZ2002404A patent/CZ2002404A3/en unknown
- 2000-08-11 TR TR2002/00353T patent/TR200200353T2/en unknown
- 2000-08-11 MX MXPA02001369A patent/MXPA02001369A/en unknown
- 2000-08-11 JP JP2001514958A patent/JP2003527319A/en not_active Withdrawn
- 2000-08-11 WO PCT/US2000/022081 patent/WO2001010441A1/en active IP Right Grant
- 2000-08-11 SK SK191-2002A patent/SK1912002A3/en unknown
- 2000-08-11 CN CN00814045A patent/CN1378448A/en active Pending
- 2000-08-11 IL IL14803100A patent/IL148031A0/en unknown
- 2000-08-11 CA CA002379322A patent/CA2379322A1/en not_active Abandoned
- 2000-08-11 ES ES00957398T patent/ES2204354T1/en active Pending
-
2002
- 2002-02-08 NO NO20020622A patent/NO20020622L/en not_active Application Discontinuation
- 2002-02-08 HR HR20020120A patent/HRP20020120A2/en not_active Application Discontinuation
- 2002-02-08 BG BG106400A patent/BG106400A/en unknown
- 2002-02-11 LT LT2002017A patent/LT5004B/en unknown
- 2002-11-08 HK HK02108111.5A patent/HK1046636A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU781461B2 (en) | 2005-05-26 |
YU9502A (en) | 2005-06-10 |
CN1378448A (en) | 2002-11-06 |
US6465496B1 (en) | 2002-10-15 |
CA2379322A1 (en) | 2001-02-15 |
EP1207880A4 (en) | 2004-09-01 |
HUP0204318A3 (en) | 2005-03-29 |
WO2001010441A1 (en) | 2001-02-15 |
NO20020622L (en) | 2002-03-14 |
HUP0204318A2 (en) | 2003-05-28 |
BG106400A (en) | 2002-08-30 |
AU781461C (en) | 2006-02-23 |
ES2204354T1 (en) | 2004-05-01 |
EP1207880A1 (en) | 2002-05-29 |
TR200200353T2 (en) | 2002-06-21 |
MXPA02001369A (en) | 2005-08-26 |
AU6902600A (en) | 2001-03-05 |
KR20020025217A (en) | 2002-04-03 |
HK1046636A1 (en) | 2003-01-24 |
HRP20020120A2 (en) | 2003-10-31 |
DE00957398T1 (en) | 2004-04-15 |
JP2003527319A (en) | 2003-09-16 |
IL148031A0 (en) | 2002-09-12 |
NO20020622D0 (en) | 2002-02-08 |
SK1912002A3 (en) | 2002-07-02 |
CZ2002404A3 (en) | 2002-06-12 |
LT2002017A (en) | 2002-11-25 |
LT5004B (en) | 2003-03-25 |
SI20816A (en) | 2002-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23817A (en) | 4-Phenyl-pyridine derivatives | |
GC0000183A (en) | 3-Phenyl-pyridine derivatives | |
GC0000338A (en) | 5-Phenyl-pyrimidine derivatives | |
IL148031A0 (en) | Torsemide polymorphs | |
EG23070A (en) | Novel propargylether derivatives | |
HK1044940A1 (en) | Isoxazolecarboxamide derivatives | |
GC0000191A (en) | 4-Phenyl-pyrimidine derivatives | |
HUP0300241A3 (en) | Processes for preparing torsemide intermediate | |
HUP0204217A3 (en) | Novel a-500359 derivatives | |
GB9925880D0 (en) | B-Carboline derivatives | |
HK1048638A1 (en) | Cyclopenteneone derivatives | |
HK1045987A1 (en) | 3-amino-2-benzyl-1-phenyl-propane derivatives | |
GC0000256A (en) | Ethanesulfonyl-piperidine derivatives | |
AP2001002327A0 (en) | 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives | |
IL154457A0 (en) | Mircronized torsemide | |
GB9921851D0 (en) | Structural elements | |
GB0027081D0 (en) | Solution | |
GB2357543B (en) | Structural members | |
TW433433U (en) | Improved lampstand | |
AU1555P (en) | Maroochy Sundew Fragaria xananassa | |
AU2789P (en) | Gaviota Fragaria xananassa | |
AU2790P (en) | Diamante Fragaria xananassa | |
TW453269U (en) | Improved structure for bow-saw | |
TW386346U (en) | Improved dovecote | |
AU137033S (en) | Blouse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |